Trends in Systemic Sclerosis Mortality Over Forty‐Eight Years, 1968–2015: A US Population

Trends in Systemic Sclerosis Mortality Over Forty‐Eight Years, 1968–2015: A US Population–Based Study

Published:2021-08-31 Issue:10 Volume:73 Page:1502-1510
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Yen Eric Y.¹,Singh Devanshu R.²,Singh Ram R.³^ORCID

Affiliation:

1. University of California David Geffen School of Medicine Los Angeles

2. University of California David Geffen School of Medicine, Los Angeles, and Whiting School of Engineering and Zanvyl Krieger School of Arts and Sciences Johns Hopkins University Baltimore Maryland

3. University of California David Geffen School of Medicine, and Jonsson Comprehensive Cancer Center Los Angeles

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute of Allergy and Infectious Diseases

National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24411

Reference46 articles.

1. Clinical and laboratory profile of systemic sclerosis in northern India;Kumar A;J Assoc Physicians India,1990

2. Systemic sclerosis

3. Systemic sclerosis associated pulmonary hypertension: improved survival in the current era

4. Mortality and survival in systemic sclerosis: Systematic review and meta-analysis

5. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of systemic sclerosis in Quebec, Canada: a population-based study;The Lancet Regional Health - Americas;2024-07

2. Associations of the circulating levels of cytokines with risk of systemic sclerosis: a bidirectional Mendelian randomized study;Frontiers in Immunology;2024-02-28

3. A Multicenter Study: Demographic, Immunological and Clinical Characteristics in Systemic Sclerosis Patients in Latvia.;2023-09-05

4. Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: A subgroup analysis of a global, randomised, controlled Phase 3 trial;Modern Rheumatology;2023-07-04

5. Causes and predictors of mortality in South Africans with systemic sclerosis;Rheumatology & Autoimmunity;2023-06